Qi; Zhiqi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Qi; Zhiqi.The latest application filed is for "fused tricyclic heterocyclic compounds as hiv integrase inhibitors".

Company Profile

1.8.17

Qi; Zhiqi - Shanghai CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Fused Tricyclic Heterocyclic Compounds As Hiv Integrase Inhibitors App 20210040096 - Yu; Tao ; et al.	2021-02-11
Piperidine or piperazine linked imidazole and triazole derivatives and methods of use Grant 10,745,377 - Coburn , et al. A	2020-08-18
TrkA kinase inhibitors, compositions and methods thereof Grant 10,556,900 - Stump , et al. Feb	2020-02-11
Fused Tricyclic Heterocyclic Compounds As Hiv Integrase Inhibitors App 20190322666 - Yu; Tao ; et al.	2019-10-24
Imidazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug Grant 9,981,969 - Coburn , et al. May 29, 2	2018-05-29
Aryl linked imidazole and triazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug Grant 9,975,888 - Coburn , et al. May 22, 2	2018-05-22
Trka Kinase Inhibitors, Compositions And Methods Thereof App 20180105518 - Stump; Craig A. ; et al.	2018-04-19
Fused Tricyclic Heterocyclic Compounds As Hiv Integrase Inhibitors App 20180099967 - Yu; Tao ; et al.	2018-04-12
TrkA kinase inhibitors, compositions and methods thereof Grant 9,862,707 - Mitchell , et al. January 9, 2	2018-01-09
TrkA kinase inhibitors, compositions and methods thereof Grant 9,815,846 - Mitchell , et al. November 14, 2	2017-11-14
Fused Tricyclic Heterocyclic Compounds As Hiv Integrase Inhibitors App 20170190701 - Yu; Tao ; et al.	2017-07-06
Trka Kinase Inhibitors, Compositions And Methods Thereof App 20170114071 - Mitchell; Helen ; et al.	2017-04-27
Trka Kinase Inhibitors, Compositions And Methods Thereof App 20170107204 - Mitchell; Helen ; et al.	2017-04-20
Sulfonamide derivatives and methods of use thereof for improving the pharmacokinetics of a drug Grant 9,556,202 - Coburn , et al. January 31, 2	2017-01-31
Aryl Linked Imidazole And Triazole Derivatives And Methods Of Use Thereof For Improving The Pharmacokinetics Of A Drug App 20160297809 - Coburn; Craig A. ; et al.	2016-10-13
Piperidine Or Piperazine Linked Imidazole And Triazole Derivatives And Methods Of Use Thereof For Improving The Pharmacokinetics Of A Drug App 20160297792 - Coburn; Craig A. ; et al.	2016-10-13
Imidazole Derivatives And Methods Of Use Thereof For Improving The Pharmacokinetics Of A Drug App 20160108048 - Coburn; Craig A. ; et al.	2016-04-21
Sulfonamide Derivatives And Methods Of Use Thereof For Improving The Pharmacokinetics Of A Drug App 20150197531 - Coburn; Craig A. ; et al.	2015-07-16
Sulfonamide Derivatives And Methods Of Use Thereof For Improving The Pharmacokinetics Of A Drug App 20140005103 - Coburn; Craig A. ; et al.	2014-01-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.